Whats Wrong With current Semantic Web Reasoning (and how to fix it)
Regulatory Perspectives on the Thorough QT/QTc Study 2005 FDA/Industry Workshop Washington DC September 16, 2005 Juan (Joanne) Zhang, Ph.D. CDER/FDA *Acknowledgement:
Frank van Harmelen Vrije Universiteit Amsterdam The Information Universe of the (Near) Futur e Creative Commons License: allowed to share & remix, but.
Michael Witbrock Cycorp [email protected]@cycorp.eu Sept 4 th 2009 Michael Witbrock Cycorp, [email protected] Sept 4 th 2009.
11 the added value of cellular analysis in early clinical trials roger greathead - pra international
Move Your Research Out of the Ivory Tower and Impact Health: Translating Early-Stage Science to the Market and Improvements in Health
Clinical Trial Design Considerations for Therapeutic Cancer ...
An introduction to Medical Communications Andy Shepherd Senior Medical Writer.
Design and Statistical Analysis of Thorough QT (TQT) Studies Yi Tsong, Ph.D., CDER/FDA Co-author – Joanne Zhang, Ph.D., CDER/FDA The opinions presented.
Searching for Efficacy Biomarker in Early Clinical Development – An Example of Using NGS in Early Oncology Development Feng Gao, Jacob Zhang, Godwin Yung.
February 27, 2014 Margaret Anderson Executive Director, FasterCures The Evolving Role of Patients in the R&D Ecosystem.
Design and Statistical Analysis of Thorough QT (TQT) Studies